Form 4: Lemaitre Vascular Director Roberts Reports Stock Transactions

David Roberts, a director and officer at Lemaitre Vascular, reports acquisition and disposal of common stock and dividend equivalent rights related to performance share units.

Summary

• On February 29, 2024, David Roberts, a Director and President of Lemaitre Vascular, engaged in transactions involving the company's common stock.
• Roberts acquired 2,649 shares of common stock upon settlement of a Performance Share Unit (PSU) award granted on December 12, 2022, at a price of $0.
• He also acquired 6 shares upon the release of dividend equivalent rights.
• 196 shares were withheld by the issuer to satisfy tax obligations related to the vesting of performance stock units, with a price of $70.
• Following these transactions, Roberts beneficially owns 19,139 shares of Lemaitre Vascular common stock and 20,059.2 dividend equivalent rights.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The transactions are routine and reflect standard compensation practices. The acquisition of shares through PSU settlement is a positive sign.

Positives

• The acquisition of shares through PSU settlement indicates confidence in the company's performance and future prospects.

Negatives

• The disposal of shares to cover tax obligations could be seen as a minor negative, although it's a standard practice.

Future Outlook

The vesting schedule of the PSU award suggests continued alignment of executive compensation with company performance over the next three years from the grant date (December 12, 2022).

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. This filing indicates standard compensation practices involving stock-based awards.

Stakeholder Impact

• The transactions provide transparency to shareholders regarding executive compensation and ownership.

Key Dates